Ankit Mahadevia

Chairman

CEO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

SPRO

Current role

Chairman, CEO, Board Member

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2023	Spero Therapeutics, Inc. (SPRO)	Former President and Chief Executive Officer	$379,220	$508,000	$999,998	—	—	$498,687	$2,385,905
2022	Spero Therapeutics, Inc. (SPRO)	Former President and Chief Executive Officer	$633,750	$254,000	$1,499,998	$1,499,324	$342,900	$9,733	$4,239,705
2021	Spero Therapeutics, Inc. (SPRO)	Former President and Chief Executive Officer	$590,417	—	$1,300,000	$2,650,765	$327,618	$6,245	$4,875,045
2020	Spero Therapeutics, Inc. (SPRO)	Chief Executive Officer	$536,667	—	—	$1,153,962	$424,049	$6,110	$2,120,788
2019	Spero Therapeutics, Inc. (SPRO)	Chief Executive Officer	$497,083	—	$285,023	$752,778	$250,000	$4,490	$1,789,374
2018	Spero Therapeutics, Inc. (SPRO)	Chief Executive Officer	$465,000	—	—	—	$255,750	$574	$721,324

Earnings-call appearances and filed executive appointments or departures, newest first.